Free Trial

Astera Labs, Inc. (NASDAQ:ALAB) CEO Jitendra Mohan Sells 106,510 Shares

Astera Labs logo with Computer and Technology background

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) CEO Jitendra Mohan sold 106,510 shares of the business's stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $94.54, for a total value of $10,069,455.40. Following the completion of the transaction, the chief executive officer now owns 521,008 shares of the company's stock, valued at $49,256,096.32. This represents a 16.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.

Jitendra Mohan also recently made the following trade(s):

  • On Thursday, May 29th, Jitendra Mohan sold 14,200 shares of Astera Labs stock. The shares were sold at an average price of $100.00, for a total value of $1,420,000.00.
  • On Monday, May 19th, Jitendra Mohan sold 128,250 shares of Astera Labs stock. The stock was sold at an average price of $90.02, for a total transaction of $11,545,065.00.
  • On Friday, May 16th, Jitendra Mohan sold 91,337 shares of Astera Labs stock. The stock was sold at an average price of $90.67, for a total transaction of $8,281,525.79.
  • On Wednesday, May 14th, Jitendra Mohan sold 75,000 shares of Astera Labs stock. The stock was sold at an average price of $90.90, for a total value of $6,817,500.00.
  • On Thursday, May 8th, Jitendra Mohan sold 75,000 shares of Astera Labs stock. The shares were sold at an average price of $71.05, for a total value of $5,328,750.00.

Astera Labs Stock Performance

ALAB stock traded up $6.62 during midday trading on Wednesday, reaching $99.53. 4,521,735 shares of the company traded hands, compared to its average volume of 4,131,262. The business has a 50 day moving average of $80.16 and a 200-day moving average of $92.21. Astera Labs, Inc. has a 52-week low of $36.22 and a 52-week high of $147.39. The firm has a market capitalization of $16.41 billion, a price-to-earnings ratio of 452.43, a P/E/G ratio of 4.36 and a beta of 1.39.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, topping the consensus estimate of $0.28 by $0.05. The company had revenue of $159.44 million for the quarter, compared to the consensus estimate of $151.55 million. Astera Labs had a net margin of 8.44% and a return on equity of 2.57%. The firm's revenue was up 144.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.10 EPS. Research analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in ALAB. Empowered Funds LLC purchased a new position in Astera Labs during the fourth quarter valued at approximately $60,000. Rhumbline Advisers grew its stake in Astera Labs by 371.4% in the fourth quarter. Rhumbline Advisers now owns 99,949 shares of the company's stock valued at $13,238,000 after purchasing an additional 78,746 shares during the last quarter. Principal Securities Inc. purchased a new position in Astera Labs in the fourth quarter valued at about $55,000. State of New Jersey Common Pension Fund D purchased a new position in shares of Astera Labs in the 4th quarter worth approximately $2,921,000. Finally, Principal Financial Group Inc. purchased a new position in Astera Labs in the fourth quarter worth $1,388,000. Hedge funds and other institutional investors own 60.47% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on ALAB. Barclays increased their price target on Astera Labs from $70.00 to $75.00 and gave the stock an "overweight" rating in a report on Wednesday, May 7th. Stifel Nicolaus cut their price objective on shares of Astera Labs from $150.00 to $100.00 and set a "buy" rating on the stock in a report on Thursday, April 17th. Susquehanna began coverage on Astera Labs in a research note on Friday, May 16th. They issued a "neutral" rating and a $80.00 target price on the stock. Evercore ISI boosted their target price on shares of Astera Labs from $87.00 to $104.00 and gave the company an "outperform" rating in a research note on Wednesday, May 21st. Finally, Raymond James Financial assumed coverage on Astera Labs in a research report on Friday, March 14th. They set an "outperform" rating and a $82.00 price target on the stock. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of $100.00.

View Our Latest Research Report on Astera Labs

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

See Also

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines